prostate cancer inositol hexaphosphate efficacy mechanisms pubmed ncbi abstract extensive scientific data suggesting potential role dietary non-dietary phytochemicals prevention control prostate cancer pca growth progression pca disease elderly male populations slower rate growth progression compared cancers candidate disease preventive intervention pca growth progression involve aberrant mitogenic survival signaling deregulated cell cycle progression accompanied gradual accumulation genetic epigenetic period years mechanisms including overexpression growth survival angiogenic factors receptors loss/decrease tumor suppressor num retinoblastoma cyclin-dependent kinase inhibitor implicated pca growth progression phytochemicals targeting molecular events promising role pca prevention and/or therapy inositol hexaphosphate ip num major constituent cereals legumes nuts oil seeds soybean orally over-the-counter dietary/nutrient supplement recognised offering health benefits toxicity vitro anticancer efficacy ip num observed human mouse rat prostate cancer cells completed studies show oral feeding ip num inhibits human pca xenograft growth nude mice toxicity recently completed pilot study observed similar preventive effects ip num prostate tumorigenesis tramp model mechanistic studies ip num targets mitogenic survival signaling cell cycle progression pca cells ip num shown target molecular events angiogenesis ip num pleiotropic molecular targets efficacy pca suitable candidate agent preventive intervention malignancy humans 
